Induction of immune responses to isoaspartyl-modified antigens

Details Induction of immune responses to isoaspartyl-modified antigens Induction of immune responses to isoaspartyl-modified antigens

2003-07-03

2009-12-01

Canella, Karen A (Department: 1643)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

C424S234100, C424S277100, C530S402000, C530S403000

Reexamination Certificate

active

07625567

ABSTRACT:
The present invention is directed to a method of enhancing the immune response of a patient relative to the normal immune response, by administering isoaspartyl-modified proteins, peptides, or cells, to a patient. The present invention is also directed to vaccines containing the isoaspartyl-modified proteins, peptides, or cells, as well as antibodies reactive with the isoaspartyl-modified proteins, peptides, or cells.

REFERENCES:
patent: 5169862 (1992-12-01), Burke et al.
patent: 5298490 (1994-03-01), Heavner et al.
patent: 5565202 (1996-10-01), Witter
patent: 5582831 (1996-12-01), Shinitzki
patent: 5733540 (1998-03-01), Lee
patent: 5872104 (1999-02-01), Vermeulen et al.
patent: 5965381 (1999-10-01), Bruggen et al.
patent: 6812023 (2004-11-01), Lamparski et al.
patent: WO 97/33612 (1997-09-01), None
patent: WO97/34613 (1997-09-01), None
Bodey et al, (Anticancer Research, 2000, vol. 20, pp. 2665-2676).
Schultze et al (Trends in Immunology, 2004, vol. 25, pp. 659-664).
Addissson et al (PNAS, vol. 92, pp. 8522-8526).
Le Fur et al (PNAS, 1997, vol. 94, pp. 7561-7565).
Abstract of Wheeler (Salud p'ublica de M'exico, (Jul.-Aug. 1997) 39 (4) 283-7).
Efferson et al (Anticancer research, 2005, vol. 25, pp. 715-724.
Bachman et al (Journal of Immunology, 2005, vol. 175, pp. 4677-4685).
Ramakrishna and Shinitzky (Cancer Immunol Immunother, 1991, vol. 33, pp. 1-8).
Desrivieres et al (JBC, 1997, vol. 272, pp. 2470-2476).
Azorsa et al (Blood, 1991, vol. 78, pp. 280-284).
Mamula, Immunological Rev, 1998, vol. 164, pp. 231-239.
Mamula et al, J Biol Chem, 1999, vol. 274, pp. 22321-22327.
Aswad et al (Journal of Pharmaceutical and Biomedical Analysis, 2000, vol. 21, pp. 1129-1136).
Nossal, Annual Review in Immunology, 1983, vol. 1, pp. 33-62.
Sabin et al, JAMA, 1984, vol. 251, pp. 2988-2993.
Lycke et al, Sandinavian Journal of Immunology, 1987, vol. 25, pp. 407-412.
Smith et al (Immunology, 2002, vol. 106, pp. 144-158).
Mamula et al (Journal of Biological Chemistry, 1999, vol. 274, pp. 22321-22327).
The abstract of Disis et al (Critical Reviews in Immunology, 1998, vol. 18, pp. 37-45).
Gene Bank Accession No. BAA32580, Nov. 9, 2007.
Ryttersgaard, C., et al., “Crystal Structure of Human L-Isoaspartyl Methyltransferase,”J. Biol. Chem. 277:10642-10646. (Mar. 22, 2002), The American Society for Biochemistry and Molecular Biology, Inc. (published online Jan. 2002).

Affiliated with

Also associated with

Rating

Induction of immune responses to isoaspartyl-modified antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Induction of immune responses to isoaspartyl-modified antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Induction of immune responses to isoaspartyl-modified antigens will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4083248